Related Experiment Videos
Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality
A G Stack1, A Hanley, L F Casserly
1Division of Nephrology, Department of Medicine, University Hospital Limerick, Limerick, Ireland. austin.stack@ul.ie
Insights
Gout and high serum uric acid levels independently increase mortality risk. Higher uric acid concentrations further elevate these risks, particularly for cardiovascular events in the general population.
Area of Science:
- Cardiovascular Health
- Metabolic Disorders
- Epidemiology
Background:
- Gout and elevated serum uric acid are linked to mortality.
- Their combined impact on mortality in the general population requires further investigation.
Purpose of the Study:
- To examine the independent and combined effects of gout and serum uric acid on mortality in the U.S. population.
Main Methods:
- Utilized data from 15,773 U.S. adults (Third National Health and Nutrition Examination Survey).
- Linked baseline data (1988-1994) with mortality data through 2006.
- Employed multivariable Cox proportional hazards regression to determine mortality risks.
Main Results:
- Gout independently increased total mortality (HR 1.42) and cardiovascular mortality (HR 1.58).
- Each 1 mg/dL increase in uric acid raised total and cardiovascular mortality risks (HR 1.16).
- Conjoint analysis showed elevated mortality risks with higher uric acid levels in gout patients.
Conclusions:
- Gout and serum uric acid are independent risk factors for total and cardiovascular mortality.
- Mortality risk escalates with increasing serum uric acid concentrations.
Background:
Gout and serum uric acid are associated with mortality but their simultaneous contributions have not been fully evaluated in the general population.
Purpose:
To explore the independent and conjoint relationships of gout and uric acid with mortality in the US population.
Methods:
Mortality risks of gout and serum uric acid were determined for 15 773 participants, aged 20 years or older, in the Third National Health and Nutrition Examination Survey by linking baseline information collected during 1988-1994 with mortality data up to 2006. Multivariable Cox proportional hazards regression determined adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for each exposure and all analyses were conducted in 2011 and 2012.
Results:
Compared with subjects without a history of gout, the multivariable HR for subjects with gout were 1.42 (CI 1.12-1.82) for total and 1.58 (CI 1.13-2.19) for cardiovascular mortality. Adjusted HRs per 59.5 µmol/l (1 mg/dl) increase in uric acid were 1.16 (CI 1.10-1.22) for total and cardiovascular mortality and this pattern was consistent across disease categories. In the conjoint analysis, the adjusted HRs for mortality in the highest two uric acid quartiles were 1.64 (CI 1.08-2.51) and 1.77 (CI 1.23-2.55), respectively, for subjects with gout, and were 1.09 (CI 0.87-1.37) and 1.37 (CI (1.11-1.70), respectively, for subjects without gout, compared with those without gout in the lowest quartile. A similar pattern emerged for cardiovascular mortality.
Conclusion:
Gout and serum uric acid independently associate with total and cardiovascular mortality. These risks increase with rising uric acid concentrations.
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Urinary Tract Calculi III: Medical Management